Literature DB >> 33622917

Outcome of Radiation Therapy for Stage IVB Uterine Cervical Cancer With Distant Lymph Nodes Metastases; Sequential Irradiation for Distant Lymph Nodes Metastases.

Yuki Mukai1, Naho Ruiz Yokota2, Madoka Sugiura3, Taichi Mizushima2, Risa Taniuchi3, Yuichi Imai2, Kotaro Hashimoto3, Yuya Tabuchi3, Etusko Miyagi2, Masaharu Hata3.   

Abstract

BACKGROUND/AIM: This study aimed to evaluate the outcome of radiation therapy for patients with distant lymph node (LN) metastases, without organ metastases from uterine cervical cancer (UCC). PATIENTS AND METHODS: Twenty-six patients with UCC with distant LN metastases received radiotherapy and were retrospectively analyzed. The sites of distant LN metastasis were as follows; Supraclavicular in 19, inguinal in nine, axillary in four, and others in three. The mean dose prescribed for these was 50 (range=40-60) Gy.
RESULTS: The 2-year overall, cause-specific, and progression-free survival, and local control of primary tumor rates were 51.3%, 51.3%, 46.9%, and 67.9%. In multivariate analysis, performance status ≥1 (p=0.007), para-aortic LN metastases (p=0.001), and lack of high-dose-rate intracavitary brachytherapy (p=0.033) were significantly associated with poor overall survival. Performance status ≥1 (p=0.004), and para-aortic LN metastases (p=0.014) were significantly associated with poor cause-specific survival.
CONCLUSION: This study demonstrated favorable local control in patients with UCC with distant LN metastases. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Uterine cervical cancer; distant lymph node metastases; external beam radiation therapy; supraclavicular lymph node metastases; three-dimensional radiation therapy

Year:  2021        PMID: 33622917      PMCID: PMC8045121          DOI: 10.21873/invivo.12365

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  24 in total

1.  Significance of and problems in adopting response evaluation criteria in solid tumor RECIST for assessing anticancer effects of advanced gastric cancer.

Authors:  Shigeaki Yoshida; Yoshinori Miyata; Atsushi Ohtsu; Narikazu Boku; Kuniaki Shirao; Yasuhiro Shimada
Journal:  Gastric Cancer       Date:  2000-12-27       Impact factor: 7.370

2.  Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Authors:  M A Quinn; J L Benedet; F Odicino; P Maisonneuve; U Beller; W T Creasman; A P M Heintz; H Y S Ngan; S Pecorelli
Journal:  Int J Gynaecol Obstet       Date:  2006-11       Impact factor: 3.561

3.  [A case of stage IVb cervical carcinoma in which survival was prolonged by two different chemotherapies and CCRT].

Authors:  Masako Ishikawa; Kentaro Nakayama; Mohammed Tanjimur Rahman; Munmun Rahman; Atsuko Katagiri; Hiroshi Katagiri; Tomoka Ishibashi; Kouji Iida; Kohji Miyazaki
Journal:  Gan To Kagaku Ryoho       Date:  2012-03

4.  Multi-institutional study of radiation therapy for isolated para-aortic lymph node recurrence in uterine cervical carcinoma: 84 subjects of a population of more than 5,000.

Authors:  Yuzuru Niibe; Masahiro Kenjo; Tomoko Kazumoto; Koichi Michimoto; Makoto Takayama; Chikako Yamauchi; Masaaki Kataoka; Kazunori Suzuki; Noriko Ii; Takashi Uno; Tsuyoshi Takanaka; Keiko Higuchi; Hideya Yamazaki; Sunao Tokumaru; Masahiko Oguchi; Kazushige Hayakawa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-01       Impact factor: 7.038

5.  Brain metastasis in patients with uterine cervical cancer.

Authors:  Jong Ha Hwang; Heon Jong Yoo; Myong Cheol Lim; Sang-Soo Seo; Sokbom Kang; Joo-Young Kim; Sang-Yoon Park
Journal:  J Obstet Gynaecol Res       Date:  2012-06-13       Impact factor: 1.730

6.  Radiation Therapy for Patients with Bone Metastasis from Uterine Cervical Cancer: Its Role and Optimal Radiation Regimen for Palliative Care.

Authors:  Masaharu Hata; Izumi Koike; Etsuko Miyagi; Mikiko Asai-Sato; Hisashi Kaizu; Yuki Mukai; Shoko Takano; Eiko Ito; Madoka Sugiura; Tomio Inoue
Journal:  Anticancer Res       Date:  2018-02       Impact factor: 2.480

7.  Biopsy of the scalene fat pad in carcinoma of the cervix uteri metastatic to the periaortic lymph nodes.

Authors:  F B Stehman; B N Bundy; P Hanjani; W C Fowler; G Abdulhay; C W Whitney
Journal:  Surg Gynecol Obstet       Date:  1987-12

8.  Radiation Therapy for Uterine Cervical Cancer With Lung Metastases Including Oligometastases.

Authors:  Yuki Mukai; Izumi Koike; Tatsuya Matsunaga; Naho Ruiz Yokota; Syoko Takano; Madoka Sugiura; Mizuki Sato; Etsuko Miyagi; Masaharu Hata
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

9.  Surgical treatment of pulmonary metastases from uterine cervical cancer. Operation method by lung tumor size.

Authors:  M Seki; K Nakagawa; S Tsuchiya; T Matsubara; I Kinoshita; S Y Weng; E Tsuchiya
Journal:  J Thorac Cardiovasc Surg       Date:  1992-10       Impact factor: 5.209

10.  Tailored radiotherapeutic strategies for disseminated uterine cervical cancer patients.

Authors:  Jung Ho Im; Hong In Yoon; Sunghoon Kim; Eun Ji Nam; Sang Wun Kim; Ga Won Yim; Ki Chang Keum; Young Tae Kim; Gwi Eon Kim; Yong Bae Kim
Journal:  Radiat Oncol       Date:  2015-04-04       Impact factor: 3.481

View more
  2 in total

1.  Subphrenic Lymph Node Metastasis Predicts Poorer Prognosis for Nasopharyngeal Carcinoma Patients With Metachronous Metastasis.

Authors:  Xue-Fang Zhang; Yan Zhang; Xu-Wei Liang; Jia-Luo Chen; Sheng-Fang Zhi; Wen-Jing Yin; Meng-Yao Wang; En-Lai Dong; Dong-Ping Chen
Journal:  Front Oncol       Date:  2021-10-01       Impact factor: 6.244

2.  The Efficacy of Radiotherapy in the Treatment of Hepatocellular Carcinoma with Distant Organ Metastasis.

Authors:  Lei Chen; Zhiwen Wang; Songlin Song; Tao Sun; Yanqiao Ren; Weihua Zhang; Mingfu Wang; Yiming Liu; Chuansheng Zheng
Journal:  J Oncol       Date:  2021-11-17       Impact factor: 4.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.